Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D/A for Acelyrin, Inc. Common Stock, par value $0.00001 per share (SLRN).
- Disclosed ownership: 0%.
- Date of event: 21 May 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 0% ownership in Acelyrin, Inc. Common Stock, par value $0.00001 per share (SLRN) on 21 May 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Manager | 0001232621 |
| KEVIN TANG | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Self | 0001178579 |
| TANG CAPITAL PARTNERS, LP | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0001191935 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0002064011 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0002036763 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0002036770 |
| CONCENTRA BIOSCIENCES, LLC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0001970065 |